Remission of Refractory PASH Syndrome Using Ixekizumab and Doxycycline

J Drugs Dermatol. 2020 Nov 1;19(11):1123. doi: 10.36849/JDD.2020.1123.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Acne Vulgaris / drug therapy*
  • Acne Vulgaris / genetics
  • Adult
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Doxycycline / therapeutic use*
  • Drug Resistance
  • Hidradenitis Suppurativa / drug therapy*
  • Hidradenitis Suppurativa / genetics
  • Humans
  • Male
  • Pyoderma Gangrenosum / drug therapy*
  • Pyoderma Gangrenosum / genetics
  • Remission Induction / methods
  • Syndrome
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Humanized
  • ixekizumab
  • Doxycycline